Indraprastha Medical Corp to hold 38th AGM on Sept 24, 2026; declares ₹4 dividend
Indraprastha Medical Corporation Limited will hold its 38th AGM on September 24, 2026, via VC/OAVM. The company proposes a dividend of ₹4 per share for FY26, amounting to ₹36.67 crore. The audited financial statements for FY26 and re-appointment of two directors will be considered. Cost auditor remuneration for FY27 is also on the agenda.
The declaration of a dividend and the release of the annual report are routine corporate actions. While positive, they do not represent a significant new development that would drastically alter the company's valuation or market position.
The announcement is positive due to the proposed dividend declaration and the filing of the annual report, indicating stable operations and shareholder returns.
Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) has announced its Annual Report for the financial year ended March 31, 2026, along with the Notice of its 38th Annual General Meeting (AGM). The AGM is scheduled to be held on September 24, 2026, at 11:30 a.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
During the AGM, the company will seek approval for the adoption of audited financial statements for the fiscal year ending March 31, 2026. Additionally, a dividend of ₹4 per equity share (40%) on face value of ₹10 each is proposed for the financial year ended March 31, 2026. The company also plans to re-appoint Prof. (Dr.) Mahesh Verma and Dr. Suneeta Reddy as directors, who are retiring by rotation. The remuneration of the Cost Auditor for the financial year ending March 31, 2027, at ₹6.50 Lacs plus statutory levies, will also be ratified.
The company has fixed September 18, 2026, as the record date for determining entitlement to the proposed dividend, which will be paid within 30 days of declaration, amounting to approximately ₹36.67 crore. The Annual Report also includes the Business Responsibility and Sustainability Report for the financial year 2025-26. The company's market capitalization as of March 31, 2026, stood at ₹3413.44 crore. The management's message highlights the company's vision for an integrated, technology-enabled healthcare ecosystem focused on 'Intelligence, Intent, and Impact'.
A plain-language summary of a public exchange filing by Indraprastha Medical Corporation Limited. Read the original for the full detail.